Epithelial-to-mesenchymal transition (EMT) is closely linked to conversion of early-stage tumours into invasive malignancies. Many signalling pathways are involved in EMT, but the key regulatory kinases in this important process have not been clearly identified. Protein kinase CK2 is a multi-subunit protein kinase, which, when overexpressed, has been linked to disease progression and poor prognosis in various cancers. Specifically, overexpression of CK2a in human breast cancers is correlated with metastatic risk. In this article, we show that an imbalance of CK2 subunits reflected by a decrease in the CK2b regulatory subunit in a subset of breast tumour samples is correlated with induction of EMT-related markers. CK2b-depleted epithelial cells displayed EMT-like morphological changes, enhanced migration, and anchorage-independent growth, all of which require Snail1 induction. In epithelial cells, Snail1 stability is negatively regulated by CK2 and GSK3b through synergistic hierarchal phosphorylation. This process depends strongly on CK2b, thus confirming that CK2 functions upstream of Snail1. In primary breast tumours, CK2b underexpression also correlates strongly with expression of EMT markers, emphasizing the link between asymmetric expression of CK2 subunits and EMT in vivo. Our results therefore highlight the importance of CK2b in controlling epithelial cell plasticity. They show that CK2 holoenzyme activity is essential to suppress EMT, and that it contributes to maintaining a normal epithelial morphology. This study also suggests that unbalanced expression of CK2 subunits may drive EMT, thereby contributing to tumour progression.
INTRODUCTION
Epithelial-to-mesenchymal transition (EMT) is part of normal cellular plasticity. It is defined by loss of epithelial cell morphology, reduced expression of proteins mediating cell-cell contacts, remodelling of the actin cytoskeleton and acquisition of a mesenchymal cell shape. [1] [2] [3] [4] Cells that have undergone EMT behave in many ways like stem cells isolated from normal or neoplastic populations. [5] [6] [7] A large number of environmental signals have been found to induce EMT, both in a developmental context and in cell culture systems. For example, during tumour progression hypoxia has been described as an important EMT regulator. 8 EMT involves multiple signalling pathways, 9 in which several protein kinases act as key regulators. 10 The vast majority of these signalling pathways converge, resulting in induction of E-cadherin repressors, in particular the Snail family genes. 11 Regulation of Snail factors is highly complex, and their protein expression levels are intimately linked to transcriptional regulation. Recent studies have highlighted the role of various post-translational modifications in regulating Snail1, these are controlled by protein kinases such as GSK-3b, CK1, PAK1, PKA and CK2. 12, 13 CK2 is a multi-subunit protein kinase composed of two catalytic subunits (aa, a 0 a 0 or aa 0 ) and a dimer of regulatory b subunits. 14 The CK2a/a 0 catalytic subunits are constitutively active and CK2b regulates catalytic activity. In mice, CK2b is essential for cell viability, and functional loss of this subunit is lethal. 15 Live-cell fluorescence imaging studies provided evidence of independent, rapid movements of CK2a and CK2b. 16 The subunits can be rapidly recruited to target specific proteins in response to various stimuli, 17 and CK2b has an important role in regulating catalytic site accessibility for some substrates. 18 For example, several transcription factors (TFs), 19 as well as the eukaryotic translation initiation factor 2b, 20 are phosphorylated by CK2 in a strictly CK2b-dependent manner.
CK2 may be involved in maintaining mammalian cell morphology, polarity 21, 22 and cell-cell adhesion, [23] [24] [25] [26] in addition to its central role in controlling several physiological and pathological processes. CK2a overexpression in the mammary gland of transgenic mice promotes hyperplasia and neoplasia, suggesting a relationship between expression and mammary tumorigenesis. 27 The CK2a gene (CSNK2A1) is one of 186 genes making up an 'invasiveness signature'. This signature is predictive of metastasis and poor survival in breast cancer. 28 In line with this, we recently showed that overexpression of CK2a in human mammary cells was correlated with metastatic risk for breast carcinoma. 29 Here, we show that, in a subset of breast tumour samples, decreased CK2b expression-leading to an overall imbalance in CK2 subunits in the cell-is correlated with induction of EMT-related markers, including altered expression of the following proteins: E-cadherin, occludin (for epithelial proteins), N-cadherin, vimentin and aSMA (for mesenchymal proteins). In line with this, CK2b-depleted epithelial cells exhibit EMT-like morphological changes associated with enhanced migration and anchorage-independent growth. Snail1 induction has a crucial role in these effects. We demonstrate that CK2b is critically required for Snail1 phosphorylation and maintenance of the epithelial phenotype. Thus, the CK2 holoenzyme acts as an upstream negative regulator of Snail1 and its downstream effectors; underexpression of CK2b in specific tumour regions may induce Snail1 and lead to EMT.
RESULTS
Unbalanced expression of CK2 subunits in a subset of breast tumour samples correlates with EMT-related markers Several studies have shown that CK2 catalytic activity is upregulated in breast tumours. 27, 30 However, how CK2b contributes to this dysregulation has not been explored. Therefore, we examined the relative expression of CK2 subunits in 20 selected breast carcinoma samples exhibiting either high or low CK2a/a 0 immunostaining. Relative levels of the three CK2 subunits varied significantly between tumour samples ( Figure 1a ). In particular, the ratio between catalytic and regulatory subunits was significantly affected in a subset of samples ( Figure 1b ). This was corroborated by immunohistochemical analysis of selected samples, showing differential CK2a/CK2b staining ( Figure 1c , compare cores #4415, #4980, #4865 with #4636). Changes in epithelial cell morphology have been associated with the presence of EMT markers in the invasion-metastasis cascade in breast cancer.
31-33 Thus, we explored a possible correlation between CK2 subunit expression and known EMT markers-E-cadherin, occludin (epithelial proteins) and N-cadherin, vimentin, aSMA (mesenchymal proteins)-in selected tumours exhibiting different CK2a/CK2b ratios ( Figure 1d) . Interestingly, in a subset of samples expressing low CK2b levels, mesenchymal markers were upregulated, whereas epithelial markers were strongly downregulated (Figure 1d , #4415, #4980 and #4865 compared with #4898 and #4636). This switch was observed to correlate with upregulation of the EMT-inducing TF Snail1. However, this correlation was not absolute, for example, with sample #4865 intermediate levels of EMT markers are detected. Since hypoxia has emerged as an important event driving EMT, we also assessed HIF-1a expression. HIF-1a is an intrinsic marker for hypoxia in breast tumour samples. Levels of this protein were significantly increased in samples expressing low CK2b (Figure 1d ), suggesting that CK2b underexpression may be associated with the hypoxic conditions found in human breast tumours.
To understand how low CK2b expression is related to an outcome of EMT, we used a gene silencing approach in various human epithelial cells.
CK2b subunit silencing triggers EMT-like morphological changes MCF10A cells are immortalized epithelial cells isolated from mammary glands. They are classed as basal cell types. 34, 35 The CK2b subunit and both catalytic subunits (CK2a/a 0 ) are expressed in early-passage WT-MCF10A cells and overall CK2 activity is measurable. Stable CK2b-knockdown cells (DCK2b) and control knockdown cells (Mock) were generated using lentiviral delivery of appropriate shRNA constructs. In DCK2b cells, CK2b expression was reduced, as assessed by western blotting and qRT-PCR ( Figure 2A , left and middle panels). CK2a expression was not affected in these cells. However, CK2a 0 was significantly reduced at the protein level. Overall CK2 activity, as assayed using the p29 peptide, was slightly increased in CK2b-depleted cells. In contrast, when assessed using a b-dependent target peptide (eukaryotic translation initiation factor 2b-derived peptide, 20 ) CK2 holoenzyme activity was dramatically reduced (Figure 2A, right panel) .
We previously observed that CK2b knockdown in epithelial cells disrupts cell polarity. 22 We therefore evaluated the effect of RNAimediated CK2b suppression on MCF10A phenotype. Parental MCF10A cells exhibited a cuboid morphology typical of epithelial cells. In contrast, CK2b-depleted cells showed an elongated fibroblast-like morphology with decreased cell-cell contacts, reminiscent of cells having undergone EMT. 36 To investigate whether EMT had effectively occurred, we assessed the expression of epithelial and mesenchymal markers (E-, N-cadherin and vimentin) associated with EMT in DCK2b cells. We used recombinant TGFb1 as a positive control to characterize the EMT-like phenotype observed in MCF10A cells as this cytokine is known to induce rapid, complete EMT in mammary epithelial cells both in vivo and in vitro. E-cadherin expression was significantly decreased in CK2b-depleted cells, and in TGFb1-treated cells ( Figure 2C , panels b and d) compared with control cells (panels a and c). As expected, the opposite was observed for N-cadherin expression ( Figure 2C , panels e-h). In addition, F-actin staining was cortical in control cells (panels i and k), whereas stress fibres were observed in DCK2b cells and in TGFb1-treated cells (panels j and l). These changes to E-cadherin and vimentin expression were confirmed both at the protein ( Figure 2B Figure  S2) ; however, this treatment also compromised cell viability, making it impossible to detect an EMT phenotype. This suggests that, although we cannot assume implication of overall CK2 kinase activity, CK2b is required to maintain the epithelial morphology of MCF10A cells. This may involve CK2b-dependent CK2 kinase activity.
Specificity of the CK2b knockdown was checked by complementation using a chicken CK2b which is expressed despite the shRNA. Expression of exogenous CK2b in DCK2b cells (DCK2b/ HAb) restored a normal epithelial phenotype (Figure 2 ).
The effect of CK2b knockdown was also evaluated in immortalized human HaCaT keratinocytes and in transformed cells (ACHN and MCF7 epithelial cells). An EMT-related phenotype was clearly induced in these epithelial cell lines by decreased CK2b expression (Supplementary Figures S3A-E) . Thus, in response to CK2b silencing, an EMT-like phenotype could be observed in various human epithelial cell lines.
Cell migration is an important aspect of EMT and invasive cancer cells, 37 we therefore investigated migration of DCK2b-MCF10A cells. Migration, as assessed by transwell assays, increased dramatically for these cells (Figure 3a) . A wound-healing assay revealed migration of DCK2b-MCF10A cells to involve a different mechanism than control, or WT cells. WT cells migrated and repopulated the wound without losing cell-cell contact at the leading edge. In contrast, and in line with previous observations, 22 CK2b -depleted cells displayed a loss of polarity associated with an individual random migratory behaviour (Supplementary Figure S4 ; Supplementary Videos S1 and S2). Thus, CK2b-depleted cells exhibited enhanced migratory potential associated with loss of polarity.
In Soft agar assays, CK2b-depleted MCF10A cells formed large spherical colonies indicative of anchorage-independent growth. However, these structures did not display invasive projections, suggesting that lack of CK2b did not promote invasive activity (Figure 3b ). This lack of complete transformation is confirmed by the fact that, when injected into nude mice either subcutaneously or into the inguinal mammary fat pads, neither Mock-nor DCK2b-MCF10A cells formed tumours (data not shown). (Figure 4a ). This suggests that, while TGFb1 treatment and CK2b depletion lead to a similar outcome, both may also affect alternative pathways. As an example, mRNA levels for Snail2/Slug were increased in response to TGFb1 (five-fold), whereas this EMT-inducing TF was not induced in DCK2b-MCF10A cells (Figures 4c and d) . Similar observations could be made for downregulated genes ( Figure 4a ): of the 439 (365 þ 74) genes downregulated in TGFb1-treated cells, 74 were also repressed in DCK2b-MCF10A cells (left panel). A total of 45 genes were commonly upregulated in both cell types (right panel). Among the genes regulated by both pathways, several mesenchymal genes (CDH2, FN1, MYL9 and VIM) were upregulated, whereas epithelial genes, such as CDH1, CDH3, CLDN1, CLDN7, OCLN, KRT5, KRT6B, COL2A1 and MUC1, tended to be downregulated (Figure 4b , right and left panels, respectively). The EMT-inducing TFs, Snail1, Twist1 and Zeb1/Zeb2, were also significantly upregulated (Figures 4c and d) , as suggested by repression of their known target genes 11 ( Figure 4b , left panel).
CK2b reduction in MCF10A cells induces Snail1
Snail1 is a key factor inducing EMT. Its regulation is complex, involving a close relationship between protein levels and transcriptional regulation. 38, 12 In our experiments, Snail1 mRNA was induced 17-fold upon CK2b attenuation (Figure 5a, left panel) . This activation was further confirmed through a pSnail1-Luciferase reporter assay, and at the protein level (Figure 5a , middle and right panels, respectively).
Snail1 is known to be phosphorylated by CK2 on Ser92. Phosphorylation at this site regulates both Snail1 stability and repressor activity in MDCK cells. 13 This phosphorylation may require physical interaction between Snail1 and CK2b, as is the case for several CK2 protein substrates. 39 We therefore investigated a potential Snail1/CK2 interaction using pull-down assays on MCF10A cell lysates. Endogenous CK2a and CK2b subunits co-precipitated with MBP-Snail1 from WT cell extracts, but not from CK2b-knockdown cell extracts (Supplementary Figure S5) . This indicates that Snail1 binds the CK2 holoenzyme through its CK2b subunit.
CK2-dependent Snail1 phosphorylation requires CK2b
To further analyse CK2-dependent Snail1 phosphorylation, MBPSnail1 was incubated with CK2a in the presence of increasing concentrations of CK2b. Snail1 was weakly phosphorylated by CK2a alone, whereas optimal phosphorylation was observed in the presence of stoichiometric amounts of CK2 catalytic and (Figure 5b, upper panel) . Mass spectrometry analysis showed that Snail1 was efficiently phosphorylated on Ser92 by the CK2 holoenzyme (Supplementary Figure S6) . This confirms that Snail1 phosphorylation is preferentially targeted by the CK2 holoenzyme, and is thereby a CK2b-driven process. In addition to CK2, other protein kinases phosphorylate Snail1. 12 Among them, GSK3b that targets Snail1 to proteasomal degradation. 40 Phosphorylation of most GSK3b substrates, including Snail1, is greatly increased by a priming phosphorylation event. 41 We therefore tested whether CK2 could synergize with GSK3b to promote Snail1 phosphorylation. MBP-Snail1 was weakly phosphorylated by GSK3b alone (Figure 5b, lower panel, lanes 1 and  2) . In contrast, priming phosphorylation of Snail1 by CK2 holoenzyme strongly enhanced its phosphorylation by GSK3b (Figure 5b, lane 4) , and CK2a alone had a weak effect on GSK3b-dependent Snail1 phosphorylation (Figure 5b, lane 3) . Thus, priming 
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by the CK2 holoenzyme is required for efficient phosphorylation of Snail1 by GSK3b, suggesting a complex synergistic hierarchal regulation of phosphorylation. In addition, GSK3b phosphorylation of a specific peptide substrate was significantly reduced in CK2b-depleted cells (data not shown). Snail1 phosphorylation was further characterized using different MCF10A cell extracts incubated with MBP-Snail1 as a substrate. Snail phosphorylation was significantly decreased in CK2b-depleted cells (Figure 5c, upper panel) . Since CK2 has a unique ability to use either ATP or GTP as co-substrate, the kinase assay was performed using [g-32 P]-GTP. This assay also showed that Snail1 phosphorylation to be significantly inhibited in CK2b-depleted cell extracts (Figure 5c, lower panel) . Next, we prepared fractions by ion-exchange chromatography of Mock or Cell extracts were prepared and HA-Snail1 stability was determined by western blot analysis using anti-HA antibodies. HSP90 was used as loading control. Densitometric quantification of the relative HA-Snail1 amounts was used to determine differential Snail1 stability in the two cell types.
CK2b-depleted cell extracts, and examined their ability to phosphorylate MBP-Snail1 (Supplementary Figure S7) . Phosphorylation and western blot analysis of Mock extracts revealed co-elution of CK2 and Snail1-dependent kinase activities. Moreover, Snail1 phosphorylation was weak in fractions from CK2b-depleted cell extracts. These results suggest that: (1) the CK2 tetrameric holoenzyme (a 2 b 2 ) present in MCF10A cell extracts is a Snail1 kinase; (2) disrupted CK2 tetramer formation as a result of CK2b attenuation significantly affects Snail1 phosphorylation.
To establish whether CK2b regulates Snail1 protein stability, HA-Snail1 was transduced into Mock-or DCK2b-MCF10A cells. Protein stability was then determined in the presence of cycloheximide, an inhibitor of translation ( Figure 5d ). As expected, the half-life for HA-Snail1 protein was short in Mock cells. In contrast, HA-Snail1 was stable in DCK2b cells, indicating that CK2b regulates its stability. in epithelial cells, Snail1 is targeted for degradation following hierarchal phosphorylation by CK2 holoenzyme and GSK3b. Silencing CK2b, or unbalanced expression of CK2 subunits leads to Snail1 induction and stabilization, EMT-related morphological changes associated with expression of mesenchymal-specific markers, enhanced migratory potential, and acquisition of transformed cell traits.
DCK2b-induced EMT is Snail1 dependent We next evaluated whether Snail1 silencing could prevent CK2b depletion from inducing an EMT phenotype. Two Snail1 shRNAs (SH1-and SH2-) were introduced into MCF10A, after selection, CK2b expression was also knocked down. Snail1 silencing was sufficient to prevent the E-/N-cadherin switch and the stress fibre formation observed in DCK2b-MCF10A cells ( Figure 6A , compare panel a with b and c, d with e and f and g with h and i). In addition, in DCK2b-MCF10A cells the E-cadherin promoter was repressed; this was released by Snail1-shRNA expression. An opposite effect was obtained for vimentin promoter activity ( Figure 6B ). Western blot analysis confirmed this mesenchymal/ epithelial marker switch upon Snail-shRNA treatment ( Figure 6C ). It is notable that Snail1 knockdown alone had no effect on CK2b expression. These complementary approaches demonstrate that Snail1 suppression was sufficient to prevent the EMT phenotype in DCK2b cells, thus indicating that Snail1 operates downstream of CK2b in the EMT interactome, and that its induction is necessary for EMT initiation in response to CK2b attenuation ( Figure 6D ).
DISCUSSION
Compared with normal tissue, primary breast cancer samples as well as breast cancer cell lines display increased CK2 activity. This increased activity is correlated with a strong CK2a expression. 28, 29, 42 In this study, we identified a subset of breast tumour samples exhibiting perturbed CK2 subunit expression, with a significant decrease in CK2b. Low CK2b expression correlated with characteristic EMT markers, including Snail1. EMT was recently shown to occur in breast cancer through mammary tumour progression studies in mice. 32 We do not know what molecular mechanisms repress CK2b expression in specific tumour samples. To date, no effector modulating CK2b expression is known, although we did observe that tumour samples expressing low levels of CK2b had upregulated HIF-1a, a marker of hypoxia. Interestingly, CK2 activity is increased in hypoxic conditions and contributes to upregulating HIF-1a transactivation activity. 43, 44 Since low oxygen levels influence the expression of some genes involved in EMT, 45 these results suggest a potential Hypoxia-CK2-EMT axis. Thus, unbalanced expression of CK2 subunits in breast cancer could participate in the molecular circuits propagating the tumour phenotype. We are currently investigating whether there is a causative link between hypoxia and CK2b underexpression.
While CK2aa 0 siRNA or TBB-treated cells were not viable over time, stable CK2b knockdown induced mesenchymal-like cells that were perfectly viable. CK2b silencing was correlated with a specific decrease in CK2a 0 protein levels, with no corresponding effect on CK2a 0 mRNA levels ( Figure 2A ; Supplementary Figures S2A and C) . Interestingly, CK2a 0 has been identified as a regulator of epithelial cell adhesion and migration. 46 Gene expression profiling revealed that TGFb-treated and DCK2b-MCF10A cells shared some regulated genes, but that each cell type also showed regulation of specific genes. Unbalanced expression of CK2 subunits strongly affects Snail1 at both the level of mRNA and protein expression. CK2 holoenzyme phosphorylates Snail1 at Ser92, through which it regulates its stability and repressive function. 13 Our data provide evidence that the CK2b subunit is required for efficient CK2-mediated Snail1 phosphorylation. Pull-down assays indicate that Snail1 binds CK2 through its regulatory subunit, thereby reinforcing the key role of CK2b in regulating its phosphorylation. Therefore, Snail1 belongs to the class of CK2b-dependent substrates. We observed that Snail1 was rapidly degraded in WT-MCF10A cells, whereas the protein was stabilized in DCK2b-MCF10A cells. In line with this, in normal epithelial cells, Snail1 would be destabilized upon phosphorylation by the CK2 holoenzyme; but in cells where CK2b expression is decreased, reduced GSK3b activity and inefficient CK2-mediated phosphorylation of Snail1 could result in its stabilization. Other studies have also highlighted the complex regulation of Snail factors, for which protein levels are intimately linked to transcriptional regulation. 47 For example, GSK3b inhibition has been shown to induce Snail1 transcription in MCF10A cells. 48 In addition to Snail1, other EMT-inducing TFs such as Zeb2 or Twist1 were also strongly induced in CK2b-depleted cells. These data indicate that decreased CK2b expression has a strong impact on several key TFs involved in activating EMT-promoting signalling pathways. These findings are consistent with another recent study showing that EMT-related TFs interact in a network, creating an 'EMT interactome'. 49 Suppression of Snail1 in DCK2b-MCF10A cells was sufficient to prevent the expression of EMT markers, suggesting that CK2 operates upstream of Snail1 in the 'EMT interactome'.
CK2b silencing in MCF10A cells induced cell migration and anchorage-independent growth. In addition, CK2b-depleted cells failed to form tumours when injected into the mammary fat pad of nude mice. Early studies demonstrated that this microenvironment provides tumour-suppressive signals. 50, 51 Mechanistically, while CK2b suppression alone failed to transform immortalized breast cells, future investigations will reveal whether CK2 cooperates with well-known oncogenes to mediate transformation.
Our findings uncover a mechanism whereby CK2 controls epithelial cell plasticity and motility ( Figure 6D ). Forced CK2b attenuation in epithelial cells invariantly leads to morphological transformations associated with activation of EMT pathways. The CK2 holoenzyme operates as an upstream kinase in the negative regulation of the EMT program, and CK2b expression may need to exceed a threshold to repress EMT and maintain an epithelial phenotype. Given that in breast tumour samples, high concordance between CK2b underexpression and EMT marker expression is observed, asymmetric expression of CK2 subunits and EMT could be linked in vivo. While not a prerequisite for invasive behaviour, EMT may be one of the several mechanisms facilitating tumour growth and progression. Consequently, unbalanced expression of CK2 subunits may contribute to inducing EMT, and reduced CK2b may represent a novel molecular alteration during malignant tumour progression.
MATERIALS AND METHODS

Cell culture and retroviral infection
MCF-10A cells from ATCC (CRL-10317, LGC Standards, Molsheim, France) are mammary epithelial cells derived from fibrocystic breast tissue from women with no family history of breast cancer and no evidence of disease. They were cultured as described. 52 Stable gene silencing was accomplished by transduction with pLKO1 lentiviruses (Sigma-Aldrich, Saint-Quentin Fallavier, France), followed by antibiotic selection (as indicated in Supplementary Table 2 ).
Western blot. Cells were lysed in RIPA buffer (10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% DOC and 1 mM EDTA) containing both protease-and phosphatase-inhibitor cocktails (SigmaAldrich; P8340, P2850, P5726). Immunoblotting was performed using primary antibodies as follows: monoclonal CK2beta-Ab (bM), polyclonal CK2a-Ab (aCoc); 53 polyclonal CK2a 0 (Bethyl Laboratories, Montgomery, TX, USA); anti-E-cadherin, anti-N-cadherin (BD Biosciences, Le Pont de Claix, France); anti-Snail1, anti-HIF-1a, anti-HSP90 (Santa-Cruz Biotechnology, Heidelberg, Germany); anti-b-actin (Abcam, Paris, France); anti-vimentin (Sigma-Aldrich); anti-aSMA (Dako France, Trappes, France) and anti-HA (12CA5), anti-Occludin (Invitrogen, Life Technologies SAS, Saint Aubin, France). Anti-Tubulin was a generous gift from Dr Lafanechè re.
Immunofluorescence. Cells were seeded on coverslips and treated as described in figure legends. Cells were either fixed in 4% paraformaldehyde for 10 min at 20 1C, and permeabilized in 0.5% Triton X-100, or were treated with 100% Methanol for 5 min at À 20 1C. E-cadherin and N-cadherin antibodies were diluted in phosphate buffered saline (0.1% CK2b downregulation induces EMT A Deshiere et al Tween-20) containing 5% Fetal Calf serum and 0.2% BSA. Secondary antibodies were Alexa 488-or Cy3-labelled goat-anti-mouse IgG. F-actin was visualized by Alexa Fluor-labelled phalloidin staining (Invitrogen) and nuclei were stained with Hoechst-33342 (Sigma-Aldrich). Cells were analysed using a Leica TCS-SP2 laser scanning confocal apparatus (Leica Microsystems SAS, Nanterre, France).
Analysis of promoter activity by luciferase assay. EMT induction was measured by transduction with reporter lentiviruses carrying E-cadherin and vimentin promoters. Renilla reniformis Luciferase plasmids (pRL-TK-Luc or pRL-CMV-Luc; Promega, Charbonnié re, France) were used to normalize transfection efficiency. The Snail1 promoter reporter 54 was transfected using the Effectene reagent (QIAGEN SAS, Courtaboeuf, France). After 48 h, cells were evaluated for Firefly and Renilla Luciferase activities using the Dual Luciferase Reporter Assay System (Promega).
Colony assay. To measure anchorage-independent growth, plates were coated with 0.6% agarose (Cambrex, Wiesbaden, Germany) in growth medium and then overlaid with a cellular suspension in 0.3% agarose (15 Â 10 3 cells/well). Plates were incubated for 2 weeks at 37 1C before imaging colonies under a transmission microscope.
Transwell migration assay. MCF10A cells were starved overnight in assay media (MCF10A media containing no epidermal growth factor and 2% serum). Cells (5 Â 10 5 ) were plated in the upper chamber of transwell plates (BD Biosciences). The bottom chambers were filled with assay medium. After 6 or 24 h incubation, bottom (migrated) cells were fixed and stained with 0.1% crystal violet.
Transcriptomic microarray data. Microarray data were deposited in the Gene Expression Omnibus (GEO) public database at NCBI, under accession number GSE28569.
Human tumour studies. Frozen samples of breast carcinomas from patients treated in Marseilles' University Teaching Hospital Gynaecologic Oncology Department were prepared for western blot analysis and tissue microarray. The tissue microarrays were designed as previously described. 55 
